Correlation Between Revelation Biosciences and Carmell Therapeutics
Can any of the company-specific risk be diversified away by investing in both Revelation Biosciences and Carmell Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revelation Biosciences and Carmell Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Revelation Biosciences and Carmell Therapeutics, you can compare the effects of market volatilities on Revelation Biosciences and Carmell Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revelation Biosciences with a short position of Carmell Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revelation Biosciences and Carmell Therapeutics.
Diversification Opportunities for Revelation Biosciences and Carmell Therapeutics
0.48 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Revelation and Carmell is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Revelation Biosciences and Carmell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Carmell Therapeutics and Revelation Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revelation Biosciences are associated (or correlated) with Carmell Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Carmell Therapeutics has no effect on the direction of Revelation Biosciences i.e., Revelation Biosciences and Carmell Therapeutics go up and down completely randomly.
Pair Corralation between Revelation Biosciences and Carmell Therapeutics
Given the investment horizon of 90 days Revelation Biosciences is expected to under-perform the Carmell Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Revelation Biosciences is 1.73 times less risky than Carmell Therapeutics. The stock trades about -0.06 of its potential returns per unit of risk. The Carmell Therapeutics is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 15.00 in Carmell Therapeutics on September 2, 2024 and sell it today you would lose (9.00) from holding Carmell Therapeutics or give up 60.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 31.45% |
| Values | Daily Returns |
Revelation Biosciences vs. Carmell Therapeutics
Performance |
| Timeline |
| Revelation Biosciences |
| Carmell Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Insignificant
Revelation Biosciences and Carmell Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Revelation Biosciences and Carmell Therapeutics
The main advantage of trading using opposite Revelation Biosciences and Carmell Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revelation Biosciences position performs unexpectedly, Carmell Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Carmell Therapeutics will offset losses from the drop in Carmell Therapeutics' long position.| Revelation Biosciences vs. Virax Biolabs Group | Revelation Biosciences vs. Kiora Pharmaceuticals | Revelation Biosciences vs. ZyVersa Therapeutics | Revelation Biosciences vs. Sonnet Biotherapeutics Holdings |
| Carmell Therapeutics vs. Sonida Senior Living | Carmell Therapeutics vs. Akanda Corp | Carmell Therapeutics vs. IPG Photonics | Carmell Therapeutics vs. NextNav Warrant |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |